Dalian Bio-Chem shareholder pledges more shares, company completes rectifications

Dalian Tongyun Investment, the controlling shareholder of Dalian Bio-Chem, has pledged an additional 3 million shares to Yantai Huazhou Investment Center, bringing its total pledged shares to 46 million. This represents 21.74% of Tongyun Investment’s holdings and 6.51% of Dalian Bio-Chem’s total share capital, which increased to 706,223,654 shares following a 2024 annual equity distribution. The pledge is for self-production and operation financing, with the principal debt maturing on March 15, 2026.

Concurrently, Dalian Bio-Chem announced it has completed rectification measures as instructed by the Dalian Securities Regulatory Bureau. These measures address issues in funds, procurement, and contract management, aiming to enhance internal controls and ensure compliance. The company confirmed that all rectifications have been implemented and will continue to be enforced.

The company stated the additional pledge was made for its own production and operation needs, highlighting ongoing financial activities while emphasizing its commitment to improving corporate governance and internal controls.